These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7492354)

  • 21. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of unresponsiveness to the superantigen staphylococcal enterotoxin B: cyclosporin A resistant split unresponsiveness unfolds in vivo without preceding clonal expansion.
    Heeg K; Bendigs S; Miethke T; Wagner H
    Int Immunol; 1993 Aug; 5(8):929-37. PubMed ID: 8398987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes.
    Hong J; Zang YCQ; Li S; Rivera VM; Zhang JZ
    Eur J Immunol; 2004 Mar; 34(3):870-881. PubMed ID: 14991617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
    Norton SD; Schlievert PM; Novick RP; Jenkins MK
    J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
    Windhagen A; Anderson DE; Carrizosa A; Balashov K; Weiner HL; Hafler DA
    J Neuroimmunol; 1998 Nov; 91(1-2):1-9. PubMed ID: 9846813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein.
    Wucherpfennig KW; Ota K; Endo N; Seidman JG; Rosenzweig A; Weiner HL; Hafler DA
    Science; 1990 May; 248(4958):1016-9. PubMed ID: 1693015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivity of normal T-cell lines to MBP isolated from normal and multiple sclerosis white matter.
    McLaurin JA; Hafler DA; Antel JP
    J Neurol Sci; 1995 Feb; 128(2):205-11. PubMed ID: 7537795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation.
    Mingari MC; Cambiaggi A; Vitale C; Schiavetti F; Bellomo R; Poggi A
    Int Immunol; 1996 Feb; 8(2):203-9. PubMed ID: 8671605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The toxic shock syndrome toxin-1 induces anergy in human T cells in vivo.
    Mahlknecht U; Herter M; Hoffmann MK; Niethammer D; Dannecker GE
    Hum Immunol; 1996 Jan; 45(1):42-5. PubMed ID: 8655359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T lymphocyte lines and clones selected against synthetic myelin basic protein 82-102 peptide from Japanese multiple sclerosis patients.
    Inobe J; Yamamura T; Kunishita T; Tabira T
    J Neuroimmunol; 1993 Jul; 46(1-2):83-90. PubMed ID: 7689597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T; Wahl C; Heeg K; Wagner H
    J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
    Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis.
    Zang YC; Kozovska MM; Hong J; Li S; Mann S; Killian JM; Rivera VM; Zhang JZ
    Eur J Immunol; 1999 May; 29(5):1692-700. PubMed ID: 10359124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of rat spleen cells by staphylococcal enterotoxins.
    Holbrook MR; Young KE; Gibbon LG; Webster CA; Tranter HS; Arbuthnott JP; Todd I
    FEMS Immunol Med Microbiol; 1993 Aug; 7(2):169-74. PubMed ID: 8401429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. V beta specificity of superantigen TSST-1 plus CD28 costimulation without APCs.
    Hu WG; Zhu XH
    Immunol Invest; 1996; 25(5-6):405-11. PubMed ID: 8915678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patients.
    Zhang JW; Chou CH; Hashim G; Medaer R; Raus JC
    Cell Immunol; 1990 Aug; 129(1):189-98. PubMed ID: 1694729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo clonal expression of T lymphocytes specific for an immunodominant N-terminal myelin basic protein epitope in healthy individuals.
    Shanmugam A; Copie-Bergman C; Caillat S; Bach JF; Tournier-Lasserve E
    J Neuroimmunol; 1995 Jun; 59(1-2):165-72. PubMed ID: 7541053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.